Longeviti Neuro Solutions

Executive Summary

Longeviti Neuro Solutions is a privately held medical device company founded in 2017 and headquartered in Baltimore, Maryland. The company specializes in innovative implantable platforms for complex brain surgery, with a core technology that enables postoperative ultrasound imaging through cranial implants. This capability allows real-time monitoring and data collection while restoring anatomical structure. Their product portfolio includes off-the-shelf and patient-specific cranial implants, as well as integrated solutions for shunts and neurostimulation leads. By addressing a critical unmet need in neurosurgery—namely, the ability to non-invasively image the brain after surgery—Longeviti's technology has the potential to improve patient outcomes and reduce healthcare costs. The company operates in the growing neurostimulation and neurosurgical device market, which is expected to see increased demand for advanced implantable technologies. While financial details and commercial traction are not publicly available, the company's unique value proposition and early-stage positioning suggest significant upside potential if regulatory and commercial milestones are achieved.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for integrated ultrasound-transparent shunt system60% success
• H2 2026Series A or B funding round to support commercialization70% success
• Q3 2026Publication of clinical outcomes using ClearView implant in peer-reviewed journal50% success